19-40008500-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178544.5(ZNF546):c.329C>A(p.Thr110Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,611,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_178544.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF546 | NM_178544.5 | c.329C>A | p.Thr110Asn | missense_variant | 6/7 | ENST00000347077.9 | NP_848639.2 | |
ZNF546 | NM_001297763.2 | c.251C>A | p.Thr84Asn | missense_variant | 6/7 | NP_001284692.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF546 | ENST00000347077.9 | c.329C>A | p.Thr110Asn | missense_variant | 6/7 | 1 | NM_178544.5 | ENSP00000339823.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251436Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135898
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1459520Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 726144
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.329C>A (p.T110N) alteration is located in exon 6 (coding exon 4) of the ZNF546 gene. This alteration results from a C to A substitution at nucleotide position 329, causing the threonine (T) at amino acid position 110 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at